Global MRD (Minimal Residual Disease) Testing Market Growth 2023-2028

Report ID: 1201640 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global MRD (Minimal Residual Disease) Testing Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for MRD (Minimal Residual Disease) Testing by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for MRD (Minimal Residual Disease) Testing by Country/Region, 2017, 2022 & 2028
    2.2 MRD (Minimal Residual Disease) Testing Segment by Type
        2.2.1 Flow Cytometry
        2.2.2 Polymerase Chain Reaction (PCR)
        2.2.3 Next-Generation Sequencing (NGS)
    2.3 MRD (Minimal Residual Disease) Testing Sales by Type
        2.3.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
        2.3.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Type (2017-2022)
        2.3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2017-2022)
    2.4 MRD (Minimal Residual Disease) Testing Segment by Application
        2.4.1 Specialty Clinics and Hospitals
        2.4.2 Diagnostic Laboratories
        2.4.3 Research Institutions
    2.5 MRD (Minimal Residual Disease) Testing Sales by Application
        2.5.1 Global MRD (Minimal Residual Disease) Testing Sale Market Share by Application (2017-2022)
        2.5.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Application (2017-2022)
        2.5.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2017-2022)
3 Global MRD (Minimal Residual Disease) Testing by Company
    3.1 Global MRD (Minimal Residual Disease) Testing Breakdown Data by Company
        3.1.1 Global MRD (Minimal Residual Disease) Testing Annual Sales by Company (2020-2022)
        3.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2020-2022)
    3.2 Global MRD (Minimal Residual Disease) Testing Annual Revenue by Company (2020-2022)
        3.2.1 Global MRD (Minimal Residual Disease) Testing Revenue by Company (2020-2022)
        3.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2020-2022)
    3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Company
    3.4 Key Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers MRD (Minimal Residual Disease) Testing Product Location Distribution
        3.4.2 Players MRD (Minimal Residual Disease) Testing Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for MRD (Minimal Residual Disease) Testing by Geographic Region
    4.1 World Historic MRD (Minimal Residual Disease) Testing Market Size by Geographic Region (2017-2022)
        4.1.1 Global MRD (Minimal Residual Disease) Testing Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global MRD (Minimal Residual Disease) Testing Annual Revenue by Geographic Region
    4.2 World Historic MRD (Minimal Residual Disease) Testing Market Size by Country/Region (2017-2022)
        4.2.1 Global MRD (Minimal Residual Disease) Testing Annual Sales by Country/Region (2017-2022)
        4.2.2 Global MRD (Minimal Residual Disease) Testing Annual Revenue by Country/Region
    4.3 Americas MRD (Minimal Residual Disease) Testing Sales Growth
    4.4 APAC MRD (Minimal Residual Disease) Testing Sales Growth
    4.5 Europe MRD (Minimal Residual Disease) Testing Sales Growth
    4.6 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Growth
5 Americas
    5.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country
        5.1.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022)
        5.1.2 Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022)
    5.2 Americas MRD (Minimal Residual Disease) Testing Sales by Type
    5.3 Americas MRD (Minimal Residual Disease) Testing Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region
        6.1.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022)
        6.1.2 APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022)
    6.2 APAC MRD (Minimal Residual Disease) Testing Sales by Type
    6.3 APAC MRD (Minimal Residual Disease) Testing Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe MRD (Minimal Residual Disease) Testing by Country
        7.1.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022)
        7.1.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022)
    7.2 Europe MRD (Minimal Residual Disease) Testing Sales by Type
    7.3 Europe MRD (Minimal Residual Disease) Testing Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa MRD (Minimal Residual Disease) Testing by Country
        8.1.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022)
        8.1.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022)
    8.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type
    8.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of MRD (Minimal Residual Disease) Testing
    10.3 Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
    10.4 Industry Chain Structure of MRD (Minimal Residual Disease) Testing
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 MRD (Minimal Residual Disease) Testing Distributors
    11.3 MRD (Minimal Residual Disease) Testing Customer
12 World Forecast Review for MRD (Minimal Residual Disease) Testing by Geographic Region
    12.1 Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Region
        12.1.1 Global MRD (Minimal Residual Disease) Testing Forecast by Region (2023-2028)
        12.1.2 Global MRD (Minimal Residual Disease) Testing Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global MRD (Minimal Residual Disease) Testing Forecast by Type
    12.7 Global MRD (Minimal Residual Disease) Testing Forecast by Application
13 Key Players Analysis
    13.1 ICON plc
        13.1.1 ICON plc Company Information
        13.1.2 ICON plc MRD (Minimal Residual Disease) Testing Product Offered
        13.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 ICON plc Main Business Overview
        13.1.5 ICON plc Latest Developments
    13.2 ArcherDX(Invitae)
        13.2.1 ArcherDX(Invitae) Company Information
        13.2.2 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
        13.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 ArcherDX(Invitae) Main Business Overview
        13.2.5 ArcherDX(Invitae) Latest Developments
    13.3 ARUP Laboratories
        13.3.1 ARUP Laboratories Company Information
        13.3.2 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
        13.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 ARUP Laboratories Main Business Overview
        13.3.5 ARUP Laboratories Latest Developments
    13.4 Asuragen
        13.4.1 Asuragen Company Information
        13.4.2 Asuragen MRD (Minimal Residual Disease) Testing Product Offered
        13.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Asuragen Main Business Overview
        13.4.5 Asuragen Latest Developments
    13.5 Cergentis B.V.
        13.5.1 Cergentis B.V. Company Information
        13.5.2 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
        13.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Cergentis B.V. Main Business Overview
        13.5.5 Cergentis B.V. Latest Developments
    13.6 Bio-Rad Laboratories
        13.6.1 Bio-Rad Laboratories Company Information
        13.6.2 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
        13.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Bio-Rad Laboratories Main Business Overview
        13.6.5 Bio-Rad Laboratories Latest Developments
    13.7 Mission Bio
        13.7.1 Mission Bio Company Information
        13.7.2 Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
        13.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Mission Bio Main Business Overview
        13.7.5 Mission Bio Latest Developments
    13.8 Guardant Health
        13.8.1 Guardant Health Company Information
        13.8.2 Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
        13.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Guardant Health Main Business Overview
        13.8.5 Guardant Health Latest Developments
    13.9 Invivoscribe
        13.9.1 Invivoscribe Company Information
        13.9.2 Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
        13.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Invivoscribe Main Business Overview
        13.9.5 Invivoscribe Latest Developments
    13.10 LabCorp
        13.10.1 LabCorp Company Information
        13.10.2 LabCorp MRD (Minimal Residual Disease) Testing Product Offered
        13.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 LabCorp Main Business Overview
        13.10.5 LabCorp Latest Developments
    13.11 Inivata
        13.11.1 Inivata Company Information
        13.11.2 Inivata MRD (Minimal Residual Disease) Testing Product Offered
        13.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Inivata Main Business Overview
        13.11.5 Inivata Latest Developments
    13.12 Natera
        13.12.1 Natera Company Information
        13.12.2 Natera MRD (Minimal Residual Disease) Testing Product Offered
        13.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Natera Main Business Overview
        13.12.5 Natera Latest Developments
    13.13 NeoGenomics Laboratories
        13.13.1 NeoGenomics Laboratories Company Information
        13.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
        13.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 NeoGenomics Laboratories Main Business Overview
        13.13.5 NeoGenomics Laboratories Latest Developments
    13.14 Opko Health
        13.14.1 Opko Health Company Information
        13.14.2 Opko Health MRD (Minimal Residual Disease) Testing Product Offered
        13.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Opko Health Main Business Overview
        13.14.5 Opko Health Latest Developments
    13.15 Quest Diagnostics
        13.15.1 Quest Diagnostics Company Information
        13.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
        13.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Quest Diagnostics Main Business Overview
        13.15.5 Quest Diagnostics Latest Developments
    13.16 Sysmex Corporation
        13.16.1 Sysmex Corporation Company Information
        13.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
        13.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Sysmex Corporation Main Business Overview
        13.16.5 Sysmex Corporation Latest Developments
    13.17 Adaptive Biotechnologies
        13.17.1 Adaptive Biotechnologies Company Information
        13.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
        13.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Adaptive Biotechnologies Main Business Overview
        13.17.5 Adaptive Biotechnologies Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. MRD (Minimal Residual Disease) Testing Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. MRD (Minimal Residual Disease) Testing Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Flow Cytometry
    Table 4. Major Players of Polymerase Chain Reaction (PCR)
    Table 5. Major Players of Next-Generation Sequencing (NGS)
    Table 6. Global MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
    Table 7. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
    Table 8. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & ($ million)
    Table 9. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2022)
    Table 10. Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2017-2022) & (US$/Unit)
    Table 11. Global MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
    Table 12. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Table 13. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022)
    Table 14. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2022)
    Table 15. Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2017-2022) & (US$/Unit)
    Table 16. Global MRD (Minimal Residual Disease) Testing Sales by Company (2020-2022) & (Units)
    Table 17. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2020-2022)
    Table 18. Global MRD (Minimal Residual Disease) Testing Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2020-2022)
    Table 20. Global MRD (Minimal Residual Disease) Testing Sale Price by Company (2020-2022) & (US$/Unit)
    Table 21. Key Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution and Sales Area
    Table 22. Players MRD (Minimal Residual Disease) Testing Products Offered
    Table 23. MRD (Minimal Residual Disease) Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global MRD (Minimal Residual Disease) Testing Sales by Geographic Region (2017-2022) & (Units)
    Table 27. Global MRD (Minimal Residual Disease) Testing Sales Market Share Geographic Region (2017-2022)
    Table 28. Global MRD (Minimal Residual Disease) Testing Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global MRD (Minimal Residual Disease) Testing Sales by Country/Region (2017-2022) & (Units)
    Table 31. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Country/Region (2017-2022)
    Table 32. Global MRD (Minimal Residual Disease) Testing Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
    Table 35. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2017-2022)
    Table 36. Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2017-2022)
    Table 38. Americas MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
    Table 39. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
    Table 40. Americas MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
    Table 41. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Table 42. APAC MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) & (Units)
    Table 43. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022)
    Table 44. APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2017-2022)
    Table 46. APAC MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
    Table 47. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
    Table 48. APAC MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
    Table 49. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Table 50. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
    Table 51. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2017-2022)
    Table 52. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2017-2022)
    Table 54. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
    Table 55. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
    Table 56. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
    Table 57. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
    Table 59. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
    Table 63. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
    Table 65. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of MRD (Minimal Residual Disease) Testing
    Table 67. Key Market Challenges & Risks of MRD (Minimal Residual Disease) Testing
    Table 68. Key Industry Trends of MRD (Minimal Residual Disease) Testing
    Table 69. MRD (Minimal Residual Disease) Testing Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. MRD (Minimal Residual Disease) Testing Distributors List
    Table 72. MRD (Minimal Residual Disease) Testing Customer List
    Table 73. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2023-2028) & (Units)
    Table 74. Global MRD (Minimal Residual Disease) Testing Sales Market Forecast by Region
    Table 75. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2023-2028) & (Units)
    Table 78. Americas MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2023-2028) & (Units)
    Table 80. APAC MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2023-2028) & (Units)
    Table 82. Europe MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2023-2028) & (Units)
    Table 84. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2023-2028) & (Units)
    Table 86. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2023-2028) & (Units)
    Table 90. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Application (2023-2028)
    Table 93. ICON plc Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 94. ICON plc MRD (Minimal Residual Disease) Testing Product Offered
    Table 95. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 96. ICON plc Main Business
    Table 97. ICON plc Latest Developments
    Table 98. ArcherDX(Invitae) Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 99. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
    Table 100. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 101. ArcherDX(Invitae) Main Business
    Table 102. ArcherDX(Invitae) Latest Developments
    Table 103. ARUP Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 104. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
    Table 105. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 106. ARUP Laboratories Main Business
    Table 107. ARUP Laboratories Latest Developments
    Table 108. Asuragen Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 109. Asuragen MRD (Minimal Residual Disease) Testing Product Offered
    Table 110. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 111. Asuragen Main Business
    Table 112. Asuragen Latest Developments
    Table 113. Cergentis B.V. Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 114. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
    Table 115. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 116. Cergentis B.V. Main Business
    Table 117. Cergentis B.V. Latest Developments
    Table 118. Bio-Rad Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 119. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
    Table 120. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 121. Bio-Rad Laboratories Main Business
    Table 122. Bio-Rad Laboratories Latest Developments
    Table 123. Mission Bio Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 124. Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
    Table 125. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 126. Mission Bio Main Business
    Table 127. Mission Bio Latest Developments
    Table 128. Guardant Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 129. Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
    Table 130. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 131. Guardant Health Main Business
    Table 132. Guardant Health Latest Developments
    Table 133. Invivoscribe Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 134. Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
    Table 135. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 136. Invivoscribe Main Business
    Table 137. Invivoscribe Latest Developments
    Table 138. LabCorp Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 139. LabCorp MRD (Minimal Residual Disease) Testing Product Offered
    Table 140. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 141. LabCorp Main Business
    Table 142. LabCorp Latest Developments
    Table 143. Inivata Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 144. Inivata MRD (Minimal Residual Disease) Testing Product Offered
    Table 145. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 146. Inivata Main Business
    Table 147. Inivata Latest Developments
    Table 148. Natera Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 149. Natera MRD (Minimal Residual Disease) Testing Product Offered
    Table 150. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 151. Natera Main Business
    Table 152. Natera Latest Developments
    Table 153. NeoGenomics Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 154. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
    Table 155. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 156. NeoGenomics Laboratories Main Business
    Table 157. NeoGenomics Laboratories Latest Developments
    Table 158. Opko Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 159. Opko Health MRD (Minimal Residual Disease) Testing Product Offered
    Table 160. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 161. Opko Health Main Business
    Table 162. Opko Health Latest Developments
    Table 163. Quest Diagnostics Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 164. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
    Table 165. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 166. Quest Diagnostics Main Business
    Table 167. Quest Diagnostics Latest Developments
    Table 168. Sysmex Corporation Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 169. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
    Table 170. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 171. Sysmex Corporation Main Business
    Table 172. Sysmex Corporation Latest Developments
    Table 173. Adaptive Biotechnologies Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
    Table 174. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
    Table 175. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 176. Adaptive Biotechnologies Main Business
    Table 177. Adaptive Biotechnologies Latest Developments
List of Figures
    Figure 1. Picture of MRD (Minimal Residual Disease) Testing
    Figure 2. MRD (Minimal Residual Disease) Testing Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate 2017-2028 (Units)
    Figure 7. Global MRD (Minimal Residual Disease) Testing Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. MRD (Minimal Residual Disease) Testing Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Flow Cytometry
    Figure 10. Product Picture of Polymerase Chain Reaction (PCR)
    Figure 11. Product Picture of Next-Generation Sequencing (NGS)
    Figure 12. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2021
    Figure 13. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2022)
    Figure 14. MRD (Minimal Residual Disease) Testing Consumed in Specialty Clinics and Hospitals
    Figure 15. Global MRD (Minimal Residual Disease) Testing Market: Specialty Clinics and Hospitals (2017-2022) & (Units)
    Figure 16. MRD (Minimal Residual Disease) Testing Consumed in Diagnostic Laboratories
    Figure 17. Global MRD (Minimal Residual Disease) Testing Market: Diagnostic Laboratories (2017-2022) & (Units)
    Figure 18. MRD (Minimal Residual Disease) Testing Consumed in Research Institutions
    Figure 19. Global MRD (Minimal Residual Disease) Testing Market: Research Institutions (2017-2022) & (Units)
    Figure 20. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2022)
    Figure 21. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application in 2021
    Figure 22. MRD (Minimal Residual Disease) Testing Revenue Market by Company in 2021 ($ Million)
    Figure 23. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company in 2021
    Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Geographic Region (2017-2022)
    Figure 25. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Geographic Region in 2021
    Figure 26. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022)
    Figure 27. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Country/Region in 2021
    Figure 28. Americas MRD (Minimal Residual Disease) Testing Sales 2017-2022 (Units)
    Figure 29. Americas MRD (Minimal Residual Disease) Testing Revenue 2017-2022 ($ Millions)
    Figure 30. APAC MRD (Minimal Residual Disease) Testing Sales 2017-2022 (Units)
    Figure 31. APAC MRD (Minimal Residual Disease) Testing Revenue 2017-2022 ($ Millions)
    Figure 32. Europe MRD (Minimal Residual Disease) Testing Sales 2017-2022 (Units)
    Figure 33. Europe MRD (Minimal Residual Disease) Testing Revenue 2017-2022 ($ Millions)
    Figure 34. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales 2017-2022 (Units)
    Figure 35. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue 2017-2022 ($ Millions)
    Figure 36. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2021
    Figure 37. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2021
    Figure 38. United States MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Canada MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Mexico MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Brazil MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 42. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2021
    Figure 43. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Regions in 2021
    Figure 44. China MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Japan MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 46. South Korea MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 48. India MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Australia MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2021
    Figure 51. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2021
    Figure 52. Germany MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 53. France MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 54. UK MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Italy MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Russia MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2021
    Figure 58. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2021
    Figure 59. Egypt MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 60. South Africa MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Israel MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Turkey MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 63. GCC Country MRD (Minimal Residual Disease) Testing Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Manufacturing Cost Structure Analysis of MRD (Minimal Residual Disease) Testing in 2021
    Figure 65. Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
    Figure 66. Industry Chain Structure of MRD (Minimal Residual Disease) Testing
    Figure 67. Channels of Distribution
    Figure 68. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global MRD Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global MRD Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global MRD Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports